The 2009 ARHP Audioconference Series will explore pertinent and timely topics that will strengthen the clinical practice of healthcare providers working with individuals with rheumatic diseases.
Systemic lupus erythematosus, often called SLE or lupus, is a chronic inflammatory disease that can affect the skin, joints, kidneys, lungs, nervous system, and other organs of the body. It is sometimes labeled the “great imitator” because its wide variety of symptoms can often be confused with other disorders. Usually, patients with SLE experience skin rashes and arthritis as well as fatigue and fever, and the disease can be fatal. However, improvements in therapy have significantly increased these patients’ quality of life and their life expectancy.
Earlier this year, I was privileged to be part of the ACR’s Advocates for Arthritis advocacy visit. My rheumatologist recommended that I apply for the event, and I was thrilled when I was accepted, even though my acceptance wasn’t necessarily competitive (I was the only patient representative from Delaware).
As small practice physicians are forced to combat increasing overhead and shriveling reimbursement, we seem to be entering an era of medical practice Darwinism—survival of those that are most fit to operate in today’s severe and unforgiving healthcare environment.
The rheumatology patient population is projected to increase dramatically over the next decade, and there is an urgent need to recruit and train the next generation of rheumatologists.
A leader is only as good as his or her team, and a team is only as good as its leader.
Anticipation—both bad and good—was the mood at this year’s ACR meeting
Dr. Sharp was a rheumatology pioneer who left a lasting mark on the field
International collaboration through ILAR promotes health equity in rheumatology
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies